sodium alendronate
PolandDrugs containing this active substance
-
The medicine is used for the treatment and prevention of osteoporosis. In postmenopausal women, it is intended to reduce the risk of fractures (including vertebral and hip fractures), and in men, it is intended to prevent vertebral and hip fractures.
Form: tablets
Active substance Dosage sodium alendronate 91.36 mg ATC: M05BA04
Manufacturer: Polpharma Pharmaceutical Works S.A.
-
The medicine is used for the treatment of osteoporosis in postmenopausal women and in men to reduce the risk of vertebral and hip fractures.
Form: tablets
Active substance Dosage sodium alendronate 91.35 mg ATC: M05BA04
Manufacturer: Teva Operations Poland Sp. z o.o.